Helicobacter pylori (H. pylori) is a risk factor for the development of gastric cancer. Here we show that infection of gastric epithelial cells with 'cag' pathogenicity island (cagPAI)-positive H. pylori induced aberrant expression of activation-induced cytidine deaminase (AID), a member of the cytidine-deaminase family that acts as a DNA-and RNA-editing enzyme, via the IjB kinase-dependent nuclear factor-jB activation pathway. H. pylori-mediated upregulation of AID resulted in the accumulation of nucleotide alterations in the TP53 tumor suppressor gene in gastric cells in vitro. Our findings provide evidence that aberrant AID expression caused by H. pylori infection might be a mechanism of mutation accumulation in the gastric mucosa during H. pylori-associated gastric carcinogenesis.
Infection with
Helicobacter pylori (H. pylori) is a risk factor for the development of gastric cancer. Here we show that infection of gastric epithelial cells with 'cag' pathogenicity island (cagPAI)-positive H. pylori induced aberrant expression of activation-induced cytidine deaminase (AID), a member of the cytidine-deaminase family that acts as a DNA-and RNA-editing enzyme, via the IjB kinase-dependent nuclear factor-jB activation pathway. H. pylori-mediated upregulation of AID resulted in the accumulation of nucleotide alterations in the TP53 tumor suppressor gene in gastric cells in vitro. Our findings provide evidence that aberrant AID expression caused by H. pylori infection might be a mechanism of mutation accumulation in the gastric mucosa during H. pylori-associated gastric carcinogenesis.
Helicobacter pylori (H. pylori) causes chronic gastric inflammation and has been defined as a class one carcinogen for human gastric cancer 1 . H. pylori can be subclassified into 'cag' pathogenicity island (cagPAI)-positive and cagPAI-negative strains based on the presence or absence of cagPAI, a 40-kb genome fragment containing 31 genes 2 . The cagPAI-positive isolates are more virulent strains that produce severe pathologic infection in humans 3 . Several studies have provided evidence linking cagPAI-positive strains to increased risk of gastric cancer [4] [5] [6] [7] . The mechanisms by which H. pylori infection increases the risk of cancer development, however, are unknown.
Activation-induced cytidine deaminase (AID), a member of the cytidine-deaminase family that acts as an editor of DNA and RNA, is an enzyme essential for somatic hypermutation and class-switch recombination, in immunoglobulin genes [8] [9] [10] . Studies have shown, however, that inappropriate expression of AID acts as a genomic mutator that contributes to tumorigenesis 11, 12 . Indeed, constitutive expression of AID in transgenic mice induces tumor development in various organs in association with high mutation frequencies 13, 14 . Moreover, many studies have shown expression of transcripts of the gene encoding AID (AICDA) in human lymphoid malignancies [15] [16] [17] [18] . Those findings led us to hypothesize that AID may be involved in the accumulation of nucleotide alterations during human gastric carcinogenesis. To gain insight into the molecular mechanism underlying the emergence of somatic mutations in various genes during gastric carcinogenesis, we investigated the relationship between somatic mutation frequency and H. pylori infection in association with AID expression in gastric epithelium.
RESULTS

H. pylori induces TP53 mutations and AID expression
To determine whether H. pylori infection leads to somatic mutations in human gastric epithelial cells, we investigated the overall mutation frequency in cells infected with various H. pylori strains. Here we focused on TP53 mutations, because inactivation and somatic mutations in this gene are frequently found in human gastric cancers 19 . We infected AGS human gastric epithelial cells with two clinical isolates of H. pylori, cagPAI positive (TN2GF4) or cagPAI negative (OK145), or the isogenic cagE-knockout mutant of TN2GF4 (DcagE, the functional cagPAI-knockout strain), and determined the sequences between exons 2 and 11 of TP53 after infection by these various H. pylori strains. We first confirmed that AGS cells infected with cagPAI-positive H. pylori responded by developing the 'hummingbird' phenotype, characterized by the elongation and spreading of cells 20 , whereas cells infected with cagPAI-negative or DcagE H. pylori did not show any phenotypic changes ( Supplementary Fig. 1 online) . Sequence analysis showed no nucleotide alterations in TP53 in cells infected with cagPAI-negative or DcagE H. pylori. In contrast, TP53 in cells infected with cagPAI-positive H. pylori had significantly higher frequencies of nucleotide alterations than did TP53 in control cells (P ¼ 0.0079; Table 1 ), suggesting that infection with cagPAI-positive H. pylori promotes somatic mutations in TP53 in AGS human gastric epithelial cells.
Next we focused on the effect of AID expression in the stomach in vivo by analyzing the gastric phenotype of AID-transgenic mice, which express AID constitutively and ubiquitously via an Aicda transgene 13 driven by chick b-actin (CAG) promoter. We found that 2/59 (3.4%) of the transgenic mice developed neoplastic lesions in the stomach. Histological examination showed that these neoplasms had the morphological appearance of microadenoma (Fig. 1a) . The finding that aberrant expression of AID could lead to tumorigenesis in the stomach prompted us to speculate that H. pylori infectioninduced mutagenesis might be mediated by AID expression in gastric epithelial cells.
Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) showed that there was only a trace amount of AICDA transcription in AGS cells in the uninfected state. There was considerable upregulation of AICDA expression, however, after infection with cagPAI-positive H. pylori (mean ± s.e.m. ¼ 173.32 ± 60.37). Unexpectedly, the AICDA expression induced by infection with cagPAIpositive H. pylori was similar to that in the AID-overexpressing human B-cell lymphoma cell line FL218 (mean ± s.e.m. ¼ 524. 22 ± 21.38) . In contrast, infection with cagPAI-negative or DcagE H. pylori had little effect on the expression of endogenous AICDA (Fig. 1b) . Immunoblot analysis showed that AID protein expression was increased substantially in response to infection with cagPAI-positive H. pylori in AGS cells, whereas cagPAI-negative or DcagE strains induced little change in AID protein expression (Fig. 1c) . We confirmed the specificity of the immunoblot results by control blotting of AID-overexpressing and AID-deficient cells 21 (Fig. 1d) . To further verify the specific induction of AID protein in human gastric epithelial cells, we assessed the expression of AID by immunostaining in the presence or absence of H. pylori infection. In AGS cells infected with cagPAI-positive H. pylori, there was AID immunoreactivity specifically in cells with the hummingbird phenotype, indicating that AID protein was indeed overexpressed in response to infection with cagPAI-positive H. pylori. In contrast, there was no AID immunostaining in cells without H. pylori infection or in cells infected with cagPAI-negative or DcagE H. pylori (Fig. 1e and data not shown) . We also confirmed that there was no DNA rearrangement of the immunoglobulin locus in AGS cells, indicating that AGS cells do not acquire a B-cell phenotype, as occurs in some breast cancer cell lines 22 ( Supplementary Fig. 2 online) . These findings collectively suggest that AID is induced in AGS human gastric epithelial cells by infection with cagPAI-positive H. pylori.
AID expression is mediated by nuclear factor-jB activation Studies have reported that infection with cagPAI-positive H. pylori is associated with increased expression of the proinflammatory transcription factor nuclear factor-kB (NF-kB) in gastric epithelial cells both in vitro and in vivo 23, 24 . Consistent with those observations, we confirmed that infection with cagPAI-positive H. pylori induced NF-kB activation, whereas cagPAI-negative or DcagE H. pylori strains induced few changes in NF-kB activity in AGS cells (Fig. 2a) . Our finding that cagPAI-positive H. pylori induced AID led us to examine Sequences between exons 2 and 11 of TP53 were amplified from cells 16 d after H. pylori infection, followed by analysis of nucleotide sequences in randomly selected clones. Data represent number of mutated clones per number of total clones examined (top row), number of mutated bases per number of total base pairs sequenced (middle row) and mean mutation frequency (bottom row). whether AID expression is mediated by an NF-kB-dependent mechanism. We incubated AGS cells with SN50, an inhibitor of NF-kB activation, or with MG132, a proteasome inhibitor that exerts suppression of NF-kB activity, then infected the cells with cagPAIpositive H. pylori. Treatment of the cells with SN50 or MG132 did not affect cell morphology and did not change the cell number or expression of transcripts encoding the cell cycle regulators cyclin D and cyclin E ( Supplementary Fig. 3 online). In these experimental conditions, pretreatment with SN50 or MG132 almost completely suppressed the H. pylori-induced increase in AICDA mRNA (Fig. 2b) .
Next we examined whether the synthesis of negative regulators of NFkB, the 'super-repressor' form of IkBa or dominant-negative forms of IkB kinases (IKKa or IKKb), affected AICDA expression. We found that the H. pylori-induced AICDA expression was reduced substantially by co-production of mutant IkBa, IKKa or IKKb ( Fig. 2c and Supplementary Fig. 3 ). To further clarify the involvement of NF-kB in AID expression, we used small interfering RNA (siRNA) to reduce expression of the endogenous noncatalytic subunit IkB kinase-g (IKKg; also known as NEMO (NF-kB essential modulator)). H. pylori failed to elicit an increase in AID protein in cells in which endogenous IKKg was 'knocked down' by siRNA, whereas H. pylori stimulated the expression of AID in control cells (Fig. 2d) . These findings indicated that the induction of AID expression in AGS human gastric cells by infection with cagPAI-positive H. pylori was achieved through the activation of NF-kB.
To further confirm that AID expression is regulated by NF-kB, we examined the effects of proinflammatory cytokine stimulation on AID expression in human gastric epithelial cells. AID protein expression in AGS and MKN-28 human gastric epithelial cells increased in response to tumor necrosis factor-a (TNF-a; Fig. 3a) . RT-PCR analyses showed that TNF-a-stimulated AGS cells had high expression of AICDA mRNA for only a short period, which peaked at 11.5 h after TNF-a treatment (Fig. 3b) . AID protein expression in AGS cells increased in a dose-dependent way with TNF-a stimulation (Fig. 3c) . Transient expression of the positive NF-kB regulators IKKa, IKKb and RelA (NF-kB subunit) resulted in an increase in the expression of endogenous AID protein in AGS cells (Fig. 3d) . However, the induction of negative NF-kB regulators, such as mutant IkBa, IKKa or IKKb, in AGS cells completely abolished the TNF-a-induced expression of AICDA mRNA (Fig. 3e) . Similarly, the TNF-a-induced expression of AID protein was totally ablated by transfection of AGS cells with siRNA targeting IKKg (Fig. 3f) . These findings support the conclusion that AID expression was regulated through the IKK-dependent NF-kB activation pathway in human gastric epithelial cells.
AID is responsible for TP53 mutations in gastric cells
We next determined whether aberrant AID expression contributes to the abnormal editing of human genes in gastric epithelial cells. For this, we established a system that allows conditional AID activation in AGS human gastric epithelial cells in response to an estrogen analog, 4-hydroxytamoxifen 25 , and investigated the mutation frequencies in TP53 and the genes encoding b-catenin (CTNNB1) and c-Myc (MYC), all of which are thought to be involved in human gastric carcinogenesis 26 . We detected no nucleotide alterations in control cells without AID activation. In contrast, significantly more nucleotide alterations were distributed throughout the entire transcribed region of TP53 in AGS cells with AID activation than in control cells (P o 0.0001; Table 2 and Supplementary Fig. 4 online) . Notably, the nucleotide alterations induced by AID activation were clustered in exons 2-4, 7 and 8 of TP53, and there were significantly fewer mutations in untranscribed regions than in transcribed regions (P o 0.0001; Table 2 gene subcloned from the same AID-activated cells also had several nucleotide alterations, 33% of which resulted in amino acid substitutions. In contrast, MYC, had no mutations among the clones isolated from the same cells with AID activation ( Table 2) . As it has been suggested that AID-induced mutation frequencies are directly proportional to transcription of the target gene 27, 28 , we examined the expression of TP53, CTNNB1 and MYC transcripts in AGS cells.
RT-PCR using total RNA extracted from AGS cells showed that there was high expression of TP53 and CTNNB1 transcripts and relatively low expression of MYC transcript ( Supplementary Fig. 4 ). Our findings are consistent with the hypothesis that AID requires gene transcription for its editing activity 27, 28 To clarify whether the increased mutation frequencies in cells infected with cagPAI-positive H. pylori were due to the induction of AID, we 'knocked down' the endogenous AID by transfecting an AIDspecific siRNA (AID siRNA; Supplementary Fig. 4 ) and assessed the mutation frequency of TP53 in AGS cells infected with cagPAI-positive H. pylori. The mean mutation frequency in the cells transfected with AID siRNA was, significantly, less than that in cells transfected with control siRNA (P ¼ 0.0141, Table 2 ).
Next, to determine the in vivo effect of H. pylori infection on AID expression and the accumulation of mutations in the gene encoding p53 (Trp53), we orally infected wild-type C57BL/6J mice with cagPAI-positive H. pylori and analyzed AID expression and Trp53 sequence in mouse stomach tissue. By immunohistochemical staining, we did not detect endogenous AID protein expression in uninfected mouse stomach. AID protein expression was upregulated, however, in gastric epithelial cells after H. pylori infection ( Supplementary Fig. 5 online). We detected no mutational changes in Trp53 in the stomachs of mice without H. pylori infection or at 1 or 2 weeks after infection. In contrast, there were a few, although not substantial, nucleotide alterations in Trp53 in the stomach at 40 weeks after H. pylori infection ( Supplementary Fig. 5 ). To further clarify the editing activity of AID on Trp53 in normal gastric epithelial cells, we analyzed Trp53 sequences in stomach tissue from 52-week-old AID-transgenic mice. Notably, there were some nucleotide alterations in Trp53 in normal gastric tissues from the mouse with constitutive AID expression, whereas we detected no Trp53 mutations in non-transgenic control mouse stomach ( Supplementary Fig. 5 ). However the difference in numbers of nucleotide alterations in Trp53 in the gastric epithelium of AID-transgenic and non-transgenic mice did not achieve statistical significance. These findings collectively suggested that H. pylori infection could induce AID expression, leading to the emergence of TP53 mutations in gastric epithelial cells in vitro and may cause Trp53 mutations in vivo; however, the in vivo data are not statistically significant.
H. pylori-positive gastric mucosa expresses AID in humans
We next analyzed the specific expression and precise localization of AID protein by immunohistochemistry in 84 human gastric tissue specimens, including H. pylori-positive chronic gastritis and gastric cancer, H. pylori-negative gastritis and gastric cancer, and normal gastric mucosa lacking H. pylori infection. In H. pylori-positive chronic gastritis tissues, we detected AID immunoreactivity in gastric epithelial cells as well as in some lymphocytes infiltrating the epithelium in 29 of 35 (83%) tissue specimens (Fig. 4a,b) . In H. pylori-infected gastric cancer tissues, AID protein was expressed in neoplastic cells in 21 of 27 (78%) specimens, localized mainly in the cytoplasm (Fig. 4c,d) .
We detected H. pylori colonization in the mucus around AID-positive gastric epithelial Table 2 AID-induced mutagenesis in cancer-related genes cells in samples from individuals with gastritis and gastric cancers ( Supplementary Fig. 6 online). Moreover, eradication of H. pylori infection resulted in substantially less AID immunoreactivity (Supplementary Fig. 6 ). In contrast, there was no AID immunostaining in any of the H. pylori-negative normal gastric mucosa and gastric cancer tissues (Fig. 4e,f) . In H. pylori-negative gastritis, we detected AID immunoreactivity in 5 of 11 tissue specimens (45%), whereas endogenous AID expression in H. pylori-unrelated gastritis was substantially lower than that in H. pylori-positive tissues (Fig. 4g) . The specificity of the AID immunostaining was confirmed by control staining performed on germinal centers of human mesenteric lymph node, which contain mostly activated B cells (Fig. 4h) . These findings indicated that AID protein is aberrantly expressed in a substantial proportion of H. pylori-associated human gastric epithelial cells, including gastric cancer. To assess the relationship between TP53 mutations and AICDA expression in gastric tissues, we analyzed the sequence of TP53 in 24 H. pylori-positive (14 gastric cancers and 10 chronic gastritis) and 8 H. pylori-negative (3 normal mucosa, 3 gastritis and 2 gastric cancers) human gastric tissue specimens. There were no endogenous AICDA transcripts (or only small amounts) in H. pylori-negative specimens, with the ratio of AICDA to 18S ribosomal RNA (18S rRNA) averaging 46.78 ± 32.76. In contrast, the ratio of mean AICDA expression to 18S rRNA in H. pylori-positive gastric tissues (1,922.38 ± 709.51) was significantly higher than that in H. pylori-negative specimens (P ¼ 0.0004; Supplementary Table 1 online). TP53 had multiple nucleotide alterations in 12 of 14 (86%) H. pylori-positive gastric cancer and 4 of 10 (40%) gastritis specimens. In contrast, nucleotide alterations in TP53 were present in only 2 of 8 (25%) H. pylori-negative tissue specimens (Supplementary Table 1) . DISCUSSION H. pylori induces active chronic gastric inflammation, which progresses to gastric adenocarcinoma in approximately 3% of affected individuals 29 . Although the mechanism underlying the H. pyloriinduced increased risk of developing gastric cancer is unclear, studies have shown that various genetic alterations occur in the gastric mucosa during chronic gastritis 26, 29, 30 , suggesting an important function for the accumulated genomic mutations in the development of gastric cancer induced by H. pylori infection. Here we have demonstrated that infection with cagPAI-positive H. pylori ectopically induced high expression of AID in human gastric epithelial cells, leading to multiple mutations in the TP53 tumor suppressor gene.
AID is a member of the cytidine deaminase family, which includes DNA-and RNA-editing enzymes. The expression of AID is highly regulated and restricted to germinal center B cells and is essential for somatic hypermutation and class-switch recombination in B cells 9 . One of the most notable abilities of AID, however, is that it is expressed ectopically. The ectopic expression of AID in nonlymphoid tissues leads to the accumulation of mutations in non-immunoglobulin genes in vitro 31 . Furthermore, constitutive and ubiquitous expression of AID in transgenic mice causes both epithelial and non-epithelial malignancies in association with high mutation frequencies 13, 14 . Here we found that some AID-transgenic mice developed gastric microadenoma. Our in vitro studies demonstrated that infection with cagPAI-positive H. pylori strongly induced aberrant AID expression in association with high TP53 mutation frequency in gastric epithelium. The prevalence of TP53 mutation in gastric cancer is approximately 40%, on average 32 . More noteworthy is that TP53 mutations are frequently present even in non-cancerous stomach with superficial gastritis caused by H. pylori colonization 29 . Thus, it is possible that the accumulation of TP53 mutations induced by aberrant AID expression is important in the pathogenesis of chronic disease by infection with cagPAI-positive H. pylori, including atrophic gastritis and the eventual development of gastric adenocarcinoma. Supporting our hypothesis, over 30% of TP53 mutations that emerged in AGS cells with AID activation corresponded to the TP53 mutations reported in various human malignancies, including gastric cancers. In contrast to the in vitro findings, there were a few, though not substantial, nucleotide alterations in mouse Trp53 gene in vivo. This may be due to the overall low efficacy of continuous H. pylori infection in wild-type mouse stomach, and due to the short duration of AID expression in AID Tg mouse stomach. Another possibility is to assume that the frequent target genes for AID-mediated mutagenesis in gastric epithelial cells might be different between humans and mice. NF-kB signaling is critical in various pathological conditions, such as inflammation and cancer development 33 . In B cells, AID expression is upregulated by stimulation with interleukin 4 and CD40 ligand 34 . CD40 ligand activates NF-kB signaling, and the 5¢ upstream region of AICDA contains putative NF-kB-binding sites 35 . Among the bacterial virulence factors defined so far, only H. pylori cagPAI is linked to the activation of NF-kB in gastric epithelial cells 24, 36 . Here we have demonstrated that inhibiting IKK-dependent NF-kB activation reduced the induction of AID expression by cagPAI-positive H. pylori infection. That is, in AGS gastric epithelial cells, H. pylori infection induced aberrant AID expression in the presence of functional cagPAI in an NF-kB-dependent way.
We have demonstrated here that endogenous AID was upregulated in H. pylori-positive chronic gastritis tissues as well as in gastric cancer specimens. It is noteworthy that H. pylori is not diffusely present throughout the stomachs of infected individuals 37 . Moreover, the number of H. pylori bacteria is much lower in atrophic gastric mucosa, where gastric cancer usually arises, and in the gastric cancer tissues 37 . Thus, it is unclear whether the AID expression in gastric tissues can be completely attributed to the direct action of H. pylori on gastric epithelial cells. It is reasonable to assume that gastric inflammation itself, accompanied by the production of proinflammatory cytokines 38 , is associated with aberrant AID expression. In fact, while H. pylori was present near the AID-expressing gastric epithelial cells, its presence did not completely correlate with immunopositivity for AID protein. In addition, we also detected endogenous AID expression in some H. pylori-unrelated gastritis tissues, although AID expression in H. pylori-negative gastritis was substantially lower than that in H. pylori-positive tissues. Thus, AID upregulation in H. pylori-infected stomach might be attributed to the following two factors: (i) direct action of H. pylori infection by the introduction of bacterial macromolecules through the type IV secretion system encoded by cagPAI 29, 36 , and (ii) inflammatory cytokines such as TNF-a that are produced in association with H. pylori-related gastric inflammation. As our findings in human tissue specimens do not provide a direct link between H. pylori infection, AID expression and TP53 mutations, the role of aberrant AID expression on human carcinogenesis via H. pylori-induced gastric inflammation requires further investigation.
In conclusion, our study showed that infection with cagPAI-positive H. pylori resulted in aberrant expression of AID in gastric epithelial cells, leading to the generation of somatic mutations in the host genome, such as those in TP53. Our data showing that cagPAI-positive H. pylori is more likely than cagPAI-negative H. pylori to be associated with AID upregulation by NF-kB activation might provide evidence linking infection with the pathogenic strain of H. pylori to the accumulation of nucleotide alterations leading to the development of gastric cancer.
METHODS
Bacteria. CagPAI-positive (TN2GF4) 39 , CagPAI-negative (OK145) and DcagE H. pylori were grown as described previously 39, 40 and were prepared for coculture experiments by transfer of bacteria to brucella broth (Becton Dickinson). For infection, H. pylori was added to AGS cells at a ratio of 50 bacteria per cell, and AGS cells were incubated at 37 1C for the period indicated in the following figures and tables: Figures 1 and 2, Tables 1 and 2 , and Supplementary Figures 1, 3 and 4.
Plasmids and reagents. Plasmids for expression of the wild-type IKKs and RelA (NF-kB subunit), the dominant-negative forms of IKKs and the 'super-repressor' form of IkBa have been described elsewhere 41 . Expression plasmid pCMV5a-AID-c-Myc-His was made by insertion of sequence encoding AID into a pCMV5a vector containing sequence encoding histidine-tagged c-Myc. NF-kB inhibitors SN50 (250 ng/ml) and MG132 (0.15 mM) were obtained from Biomol International and Calbiochem, respectively. Recombinant human TNF-a was purchased from Peprotech. Polyclonal antibodies to human AID have been described previously 42 . Antibodies to human IKKg and a-tubulin were purchased from Santa Cruz Biotechnology and Calbiochem, respectively.
Cell culture and transfection. AGS human gastric epithelial cells were grown in Ham's F12 modified medium (MP Biomedicals) supplemented with 10% (vol/ vol) FBS. Lipofectamine 2000 reagent (Invitrogen) was used for transfection of plasmids. For stable transfection, AGS cells were transfected with ScaIlinearized AID-expressing vector 25 , and the next day cells were cultured in medium containing Blasticidin S HCl (10 mg/ml; Invitrogen) until colonies of stably transfected clones grew. TransIT-TKO reagent (Mirus) was used for transfection of siRNA. The siRNA duplex specific for IKKg (NEMO) was obtained from Invitrogen. For AID 'knockdown' , cells were treated with synthesized siRNA (5¢-UUAUUGCGAAGAUAACCAAAGUCCA-3¢). An unrelated control, Stealth RNAi Negative Control Duplex (Invitrogen), was used as a control for non-sequence-specific effects.
PCR, RT-PCR and quantitative real-time RT-PCR. Oligonucleotide primers are in Supplementary Table 2 online. Human AID gene expression was quantified by quantitative real-time RT-PCR with a Real Time PCR System 7300 and TaqMan Universal PCR Master Mix (Applied Biosystems). The 6-carboxyfluorescein-labeled probe used for human AICDA was 5¢-TCGGCGTGAGACCTACCTGTGCTAC-3¢. For analysis of the quantity of isolated RNA as well as the efficiency of cDNA synthesis, target cDNA amounts were normalized to the amount of endogenous mRNA of the 'housekeeping' reference 18S rRNA 43 . For simplicity, ratios are presented as relative values, expressed as 10,000 Â target gene / 18S rRNA.
Subcloning and sequence analyses of TP53, CTNNB1 and MYC. Target sequences were amplified with Phusion High-Fidelity DNA Polymerase (Finnzymes). PCR products were subcloned into the EcoRI-XhoI sites of pcDNA3 vector (Invitrogen), followed by sequence analyses.
Immunostaining and immunohistochemistry. AGS cells were fixed for 15 min at 25 1C in 10% (wt/vol) formalin solution and were made permeable for 5 min at 25 1C with 0.1% (vol/vol) Triton X-100 solution, and endogenous peroxidase activity was 'quenched' for 30 min at 25 1C with 0.3% (vol/vol) H 2 O 2 in methanol. After being blocked with 1% (wt/vol) BSA solution, cells were first incubated at 4 1C overnight with primary polyclonal antibody specific for AID 42 or a-tubulin and then for 30 min at 25 1C with biotinylated secondary antibody. ABC reagent (avidin-biotinylated enzyme complex; Vector Laboratories) was added and cells were incubated with DAB Substrate (3,3-diaminobenzidine tetrahydrochloride; Vector Laboratories) until the desired stain intensity developed. Cells were mounted in Mount-Quick (Vector Laboratories). Human stomach tissues for immunohistochemical analysis were obtained from biopsy and autopsy specimens and were embedded in paraffin. Immunohistochemistry was done according to a published protocol 44 .
Statistics. Statistical significance (P o 0.05) was determined by the w 2 test for sequence analyses or by the Mann-Whitney U-test for real-time PCR analysis of AICDA expression.
Note: Supplementary information is available on the Nature Medicine website.
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